| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 77.2 | 79.1 |
| Gross profit | 34.0 | 36.2 |
| Profit before tax | -14.6 | -3.8 |
| Net income | -16.2 | -5.3 |
| EPS (diluted, $ a share) | $-0.61 | $-0.20 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -2.4% |
|---|---|
| Gross margin | 44.1% |
| Operating margin | -20.2% |
10-Q filed with the SEC, NASDAQ: INGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Inogen Inc: key numbers
- Share price
- $5.63Close, Nov 16
- Market cap
- $146M
- Shares outstanding
- 26MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Inogen Inc
All →Inogen Earnings Call: Key Takeaways
Inogen is undergoing a strategic pivot, divesting its rental business and implementing a $20 million cost reduction program to offset international softness and return to profitability.
Inogen Leadership Change
Inogen appointed current COO Andy Reding as President and CEO and a member of the Board of Directors, effective October 30, 2026. He succeeds Kevin R.M. Smith, whose role as an officer and employee ended on the same date. The transition occurs as the company focuses on a more streamlined commercial model following the divestiture of its U.S. rental business.
Inogen Divestiture to Rotech Healthcare Inc. for $24.8M
Inogen agreed to sell substantially all assets of its U.S. oxygen rental business to Rotech Healthcare for an estimated $24.8 million. The divestiture is intended to streamline Inogen's commercial model and shift focus toward its product supply business, supported by a new long-term supply agreement with Rotech. Upon closing, Inogen will also increase its share repurchase authorization from $30 million to $45 million.
- Value
- $24.8M
- Counterparty
- Rotech Healthcare Inc.